LND
inflammatory diseases
Advertisement
Advertisement
health

Small Molecules, Big Impact: Lilly's Bold Move to Tackle Inflammation

January 8, 2026

Lilly, a big name in medicine, is making a big move. They're buying Ventyx, a smaller company with a promising lineup of drugs. Ventyx's focus? Inflammation. They're working on small molecules that could treat a wide range of diseases caused by chronic inflammation. Think heart disease, brain disord

science

The Search for New Anti-Inflammatory Drugs: A Closer Look at P2Y14 Receptor Antagonists

January 29, 2025

Inflammation is a big deal, and it's involved in many diseases that affect people worldwide. One specific receptor, called P2Y14, plays a crucial role in these inflammatory responses. Scientists have been working on new drugs to block this receptor and reduce inflammation. They used a process called

About

Delivering news that matter to your community, powered by latest innovations and human insight.

RSS Feed

Quick Links

  • Home
  • Politics
  • Finance
  • Business
  • Science
  • Environment
  • Weather
  • Health
  • Technology

Legal

  • Privacy Policy
  • Terms of Service
2026 Copyright localnews.digital. All Rights Reserved.
Version: 0.1.34